citalopram and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

citalopram has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brody, AL; London, ED; Mandelkern, MA; Okita, K; Zorick, T	1

Trials

1 trial(s) available for citalopram and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

Article	Year
Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. The international journal of neuropsychopharmacology, 2019, 04-01, Volume: 22, Issue:4 Topics: Administration, Intravenous; Adult; Alcoholism; Benzamides; Citalopram; Corpus Striatum; Craving; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Thalamus	2019

Article

Year

Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability.

The international journal of neuropsychopharmacology, 2019, 04-01, Volume: 22, Issue:4

Topics: Administration, Intravenous; Adult; Alcoholism; Benzamides; Citalopram; Corpus Striatum; Craving; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Thalamus

2019